KALY Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy

KALY Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy

  Dallas, TX — October 1, 2019 — InvestorsHub NewsWire — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today highlighted the progress of Puration, Inc. (USOTC: PURA) reporting today a new European distribution agreement worth $4 million in potential revenue annually.  “What’s good for PURA, is good for KALY,”…

– Buffett’s 5 Top Stock Picks –

Oracle Of Omaha – His Winning Trades Genius at work describes Warren Buffett and his Berkshire Hathaway holdings. Billions of dollars have been made over the years just by sticking with Buffetts winners, With earths population now exploding well beyond 8 Billion, how many I-phones will be sold in the coming years. Bristol Meyers – Options…

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

MIRAMAR, FL — October 01, 2019 — InvestorsHub NewsWire — Generex Biotechnology Corporation (www.generex.com) (GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc. today officially launched the Excellagen 3.0 cc pre-filled syringe, which is specifically designed for use in the surgical suite. The addition of the 3cc size to the Excellagen product line…

Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative

Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative

      MIAMI, FL — October 1, 2019 — InvestorsHub NewsWire — Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces formation of its wholly owned subsidiary, RXMD Therapeutics Inc., specializing in cannabinoid-based and alternative therapy product lines.    “We are excited to make this official announcement, RXMD Therapeutics Inc.…

Puration Enters $1.7 Billion European CBD Market With New Distribution Agreement For Its EVERx CBD Sports Water

Puration Enters $1.7 Billion European CBD Market With New Distribution Agreement For Its EVERx CBD Sports Water

DALLAS, TX — October 1, 2019 — InvestorsHub NewsWire — Puration, Inc. (USOTC: PURA) today released a presentation detailing its recently announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue.  The presentation has been prepared by the company’s CEO, Brian Shibley, and is available…